Transfusional hemosiderosis in childhood cancer patients and survivors
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.31220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Jacquelyn Baskin-Miller und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hematology Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Hemosiderosis, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Children treated for cancer are at risk for adverse effects of iron due to transfusions administered during prolonged marrow suppression, which may increase exposure to toxic forms of iron, extrahepatic iron accumulation, and long‐term organ damage.
Objective
This study aimed to characterize the severity and organ distribution of clinically significant, multisystem iron overload (IO) in an at‐risk cohort of pediatric cancer patients.
Methods
This was a retrospective, cross‐sectional study of childhood cancer patients who underwent a magnetic resonance imaging (MRI) due to clinical concern for IO. Data regarding cancer type and treatment, transfusion history, MRI and laboratory results, and treatment for IO were collected. Severity of IO was analyzed by non‐parametric tests with respect to clinical characteristics.
Results
Of the 103 patients, 98% of whom had a Cancer Intensity Treatment Rating (ITR‐3) of 3 or higher, 53% (54/102) had moderate or greater hepatic siderosis, 80% (77/96) had pancreatic siderosis, 4% (3/80) had cardiac siderosis, and 45% (13/29) had pituitary siderosis and/or volume loss. Pancreatic iron was associated with both cardiac ( p = .0043) and pituitary iron ( p = .0101). In the 73 off‐therapy patients, ferritin levels were lower ( p = .0008) with higher correlation with liver iron concentration (LIC) ( p = .0016) than on‐therapy patients. Fifty‐eight subjects were treated for IO.
Conclusion
In this heavily treated cohort of pediatric cancer patients, more than 80% had extrahepatic iron loading, which occurs with significant exposure to toxic forms of iron related to decreased marrow activity in setting of transfusions. Further studies should examine the effects of exposure to reactive iron on long‐term outcomes and potential strategies for management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Hematology Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
- Children's Center for Cancer, Blood Diseases and Bone Marrow Transplantation, Children's Hospital of Los Angeles, Los Angeles, California, USA.
- Division of Pediatric Hematology Oncology, Rady Children's Hospital, San Diego, California, USA.
- Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA.
- Division of Cardiology, Children's Hospital Los Angeles, Los Angeles, California, USA.
ORCID-Profile: Jacquelyn Baskin-Miller, Julie Jaffray, David R Freyer, John Wood, Christopher C Denton
Zitieren
APA
Baskin-Miller, J., Carson, S., Jaffray, J., Fletcher, C., Singer, J., Freyer, D. R., Wood, J., Coates, T. D., & Denton, C. C. (2024). Transfusional hemosiderosis in childhood cancer patients and survivors. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31220
Vancouver
Baskin-Miller J, Carson S, Jaffray J, Fletcher C, Singer J, Freyer DR, et al. Transfusional hemosiderosis in childhood cancer patients and survivors. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31220
BibTeX
@article{BaskinMiller2024,
author = {Baskin-Miller, Jacquelyn and Carson, Susan and Jaffray, Julie and Fletcher, Craig and Singer, Jessie and Freyer, David R and Wood, John and Coates, Thomas D and Denton, Christopher C},
title = {Transfusional hemosiderosis in childhood cancer patients and survivors},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.31220}
}
EUVIMED